Blanket Purchase Agreement HT001414A0004

The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...

The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...

This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to SpecGx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned pharmaceutical manufacturer. The contract has a ceiling value of $4,154,058.30 and a period of performance through December 9, 2029. The contract is for the supply of Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths, packaged in 100-count bottles. This is a firm-fixed price,...

The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $29,637,820.29 single-award indefinite delivery/indefinite quantity (ID/IQ) contract to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer. This contract, which runs through March 3, 2031, allows DLA to issue delivery orders for a variety of injectable pharmaceutical products, including antibiotics, critical care medications, and anesthesia drugs, to support military healthcare programs and...

This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The single-award contract has a potential value up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. This includes drugs and products such as flumazenil injection, prednisone...

This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Nephron Sterile Compounding Center LLC on March 1, 2020, with a potential value of $2.5 million. The BPA is for specialized compounded intravenous solutions with no set-aside used. The period of performance extends through the last date to order of September 30, 2023. The BPA facilitates recurring orders for specific pharmaceutical products and supplies, including Phenylephrine HCI Injection,...

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The single-award, $10,819,189.25 ceiling value contract is for the supply of various generic pharmaceutical products, including tablets and capsules containing gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER, naproxen, hydralazine, and celecoxib. The...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency, to Civica Inc., a non-profit organization and manufacturer of goods. The BPA has a ceiling value of $625,000.00 and a period of performance ending on April 3, 2026. The BPA is for the procurement of the pharmaceutical products daptomycin, lorazepam, phenylephrine, and anectine. As a BPA, this contract vehicle allows the agency to place individual task orders for these products as needed...

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has a potential value of up to $5,999,999 and a period of performance through December 31, 2025. Under this IDC, DMS Pharmaceutical Group will deliver a variety of pharmaceutical and medical products on a firm fixed-price basis,...

The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to supply pharmaceutical products and medical supplies in support of Department of Defense healthcare programs. Delivery orders issued against the contract procured a range of prescription drugs, vaccines, medical implants and other supplies for distribution to military treatment facilities. Key products delivered included oncology pharmaceuticals, respiratory medications, contraceptives and...